Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.24 -0.59 (-7.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Cash from Investing Activities (2023 - 2025)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Cash from Investing Activities of -$193,301 in the quarter ended Dec 31, 2025, compared with -$43,757 a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Cash from Investing Activities (2023 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Eupraxia Pharmaceuticals reported Cash from Investing Activities of -$588,947.

  • Across earlier years, Cash from Investing Activities came in at -$75,159 in the year ended Dec 31, 2024, -$73,377 in the year ended Dec 31, 2023 and $9.83 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Eupraxia Pharmaceuticals 289.28 Mn 287.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -193,301.00
Dec 31, 2024 -43,757.00
Dec 31, 2023 -49,385.00
Sep 30, 2023 -9,602.00
API Access

Eupraxia Pharmaceuticals Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=EPRX&period=max&api_key=YOUR_API_KEY